Sartorius Stedim Biotech S.A. (EPA:DIM)
France
· Delayed Price · Currency is EUR 162.45
-2.15 (-1.31%)
Mar 9, 2026, 5:35 PM CET
Sartorius Stedim Biotech Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 265.6 | 175.1 | 310.3 | 876.1 | 414.4 | Upgrade
|
| Depreciation & Amortization | 265.8 | 259.5 | 213.2 | 162.3 | 126.4 | Upgrade
|
| Other Amortization | 52.3 | 42.2 | 23.6 | 19.4 | 15.2 | Upgrade
|
| Loss (Gain) on Equity Investments | 2.2 | 8.6 | - | - | - | Upgrade
|
| Other Operating Activities | 131.7 | 78.7 | 8.6 | -94.2 | 291.6 | Upgrade
|
| Change in Accounts Receivable | 42.9 | 38.3 | 162.1 | -65.8 | -87.3 | Upgrade
|
| Change in Inventory | -46.4 | 207.6 | 131.2 | -217.9 | -275.4 | Upgrade
|
| Change in Other Net Operating Assets | -21.9 | 5.1 | -102.6 | -67.6 | 217 | Upgrade
|
| Operating Cash Flow | 692.2 | 815.1 | 746.4 | 612.3 | 701.9 | Upgrade
|
| Operating Cash Flow Growth | -15.08% | 9.20% | 21.90% | -12.77% | 68.37% | Upgrade
|
| Capital Expenditures | -393.2 | -339.8 | -473.6 | -430.6 | -324 | Upgrade
|
| Cash Acquisitions | - | - | -2,241 | -515.6 | -141.7 | Upgrade
|
| Investment in Securities | -4.4 | -0.1 | -8.1 | - | - | Upgrade
|
| Other Investing Activities | -0.1 | -0.1 | -0.1 | -11.3 | 0.5 | Upgrade
|
| Investing Cash Flow | -397.7 | -340 | -2,723 | -957.5 | -465.2 | Upgrade
|
| Long-Term Debt Issued | 13.3 | 17.3 | 2,649 | 566.8 | 74.2 | Upgrade
|
| Long-Term Debt Repaid | -334.8 | -879.2 | -326.4 | -174.4 | -79.7 | Upgrade
|
| Net Debt Issued (Repaid) | -321.5 | -861.9 | 2,323 | 392.4 | -5.5 | Upgrade
|
| Issuance of Common Stock | 0.2 | 1,194 | 1.3 | - | - | Upgrade
|
| Repurchase of Common Stock | - | -1.9 | - | -3.2 | - | Upgrade
|
| Common Dividends Paid | -67.1 | -67.1 | -132.7 | -116.1 | -62.7 | Upgrade
|
| Other Financing Activities | -154.4 | -177.8 | -205.3 | -52.4 | -9.5 | Upgrade
|
| Financing Cash Flow | -542.8 | 84.9 | 1,986 | 220.7 | -77.7 | Upgrade
|
| Foreign Exchange Rate Adjustments | -4.5 | 2.3 | -0.3 | 8 | 4.8 | Upgrade
|
| Net Cash Flow | -252.8 | 562.3 | 9.5 | -116.5 | 163.8 | Upgrade
|
| Free Cash Flow | 299 | 475.3 | 272.8 | 181.7 | 377.9 | Upgrade
|
| Free Cash Flow Growth | -37.09% | 74.23% | 50.14% | -51.92% | 46.65% | Upgrade
|
| Free Cash Flow Margin | 10.08% | 17.10% | 9.83% | 5.20% | 13.09% | Upgrade
|
| Free Cash Flow Per Share | 3.07 | 4.91 | 2.96 | 1.97 | 4.10 | Upgrade
|
| Cash Interest Paid | 153.6 | 176.9 | 116.7 | 10.3 | 8.3 | Upgrade
|
| Cash Income Tax Paid | 149.1 | 133.5 | 135.8 | 221.2 | 166.6 | Upgrade
|
| Levered Free Cash Flow | 177.2 | 369.8 | 81.05 | 93.93 | 425.14 | Upgrade
|
| Unlevered Free Cash Flow | 263.51 | 462.3 | 153.18 | 105.3 | 431.51 | Upgrade
|
| Change in Working Capital | -25.4 | 251 | 190.7 | -351.3 | -145.7 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.